Is it useful to take Besudil mesylate tablets to reduce the size of lung nodules for one year?

The role of Belumosudil mesylate tablets (Belumosudil) in the treatment of chronic graft-versus-host disease (cGVHD) is mainly focused on improving the systemic inflammatory response and fibrosis process. In selected patients, cGVHD may affect the lungs, forming nodular or fibrotic lesions related to the immune response, especially pulmonary manifestations such as bronchiolitis obliterans (BO). When patients take besudil, if the lung nodules shrink, this may be related to the drug's regulation of the immune system, anti-fibrosis effect and impact on T cell differentiation.

However, it needs to be clear that the nature of pulmonary nodules is complex and diverse, and its causes may include infection, inflammation, autoimmune response, graft-related injury, and even neoplastic lesions. Besudil mesylate is not an "anti-nodule" drug in a broad sense. Its pharmacological mechanism is mainly to inhibit ROCK2, regulate key immune pathways such as IL-17 and IFN-γ, reduce inflammatory damage and limit fibrous tissue proliferation. Therefore, if a patient's lung nodules shrink after taking this drug, there is a certain probability that the nodules are driven by chronic inflammation or immune-related processes rather than malignant lesions. However, this phenomenon cannot be widely generalized to all types of pulmonary nodules.

Although the shrinkage of nodules after one year of taking the drug may indicate the positive effect of besudil in individual immune regulation, it cannot be directly determined from this that the drug has universal efficacy against pulmonary nodules. Especially if the nodule changes are not confirmed by histopathology, image reduction alone cannot determine whether it is directly related to drug use. More importantly, the treatment process must be accompanied by imaging follow-up and bronchoscopy or biopsy when necessary to confirm the nature and development trend of the nodules.

Reference: https://www.drugs.com/pro/rezurock.html